1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Radiopharmaceuticals Market – By Type

1.3.2        Europe Radiopharmaceuticals Market – By Application

1.3.3        Europe Radiopharmaceuticals Market – By End User

1.3.4        Europe Radiopharmaceuticals Market– By Country

2.           Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Radiopharmaceuticals Market– Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Radiopharmaceuticals Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Use of Alpha Radio Immunotherapy for Cancer Treatment

5.1.2        Rising Advancements in Nuclear Imaging Techniques

5.2         Market Restraints

5.2.1        Availability of Alternatives

5.3         Market Opportunities

5.3.1        Escalating Growth in Emerging Countries

5.4         Future Trends

5.4.1        Suring Use of Nuclear Medicines for Personalized Treatment

5.5         Impact Analysis

6.           Radiopharmaceuticals Market– Europe Analysis

6.1         Europe Radiopharmaceuticals Market Revenue Forecast and Analysis

7.           Europe Radiopharmaceuticals Market Analysis – By Type

7.1         Overview

7.2         Europe Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3         Diagnostic Nuclear Medicine

7.3.1        Overview

7.3.2        Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        SPECT

7.3.3.1          Overview

7.3.3.2          SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        PET

7.3.4.1          Overview

7.3.4.2          PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Therapeutic Nuclear Medicine

7.4.1        Overview

7.4.2        Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3        Alpha Emitters

7.4.3.1          Overview

7.4.3.2          Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4        Beta Emitters

7.4.4.1          Overview

7.4.4.2          Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5        Brachytherapy Isotopes

7.4.5.1          Overview

7.4.5.2          Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Radiopharmaceuticals Market Analysis – By Application

8.1         Overview

8.2         Europe Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

8.3         Oncology

8.3.1        Overview

8.3.2        Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Cardiology

8.4.1        Overview

8.4.2        Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Neurology

8.5.1        Overview

8.5.2        Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.           Europe Radiopharmaceuticals Market Analysis – By End User

9.1         Overview

9.2         Europe Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Imaging Centres

9.4.1        Overview

9.4.2        Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Academic and Research Centers

9.5.1        Overview

9.5.2        Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Others

9.6.1        Overview

9.6.2        Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.        Europe Radiopharmaceuticals Market – Country Analysis

10.1      Europe: Radiopharmaceuticals Market

10.1.1     Overview

10.1.2     Europe: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

10.1.2.1       Germany: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1       Germany: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2       Germany: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.1.2.1     Germany: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.2.2     Germany: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.3       Germany: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4       Germany: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.2       France: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1       France: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2       France: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.2.2.1     France: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.2.2     France: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.3       France: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4       France: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.3       UK: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1       UK: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2       UK: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.3.2.1     UK: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.2.2     UK: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.3       UK: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4       UK: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.4       Italy: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1       Italy: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2       Italy: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.4.2.1     Italy: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.2.2     Italy: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.3       Italy: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.4.4       Italy: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.5       Spain: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1       Spain: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2       Spain: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.5.2.1     Spain: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.5.2.2     Spain: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.5.3       Spain: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.5.4       Spain: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.6       Rest of Europe: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1       Rest of Europe: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2       Rest of Europe: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.6.2.1     Rest of Europe: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.6.2.2     Rest of Europe: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.6.3       Rest of Europe: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.6.4       Rest of Europe: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on Europe Radiopharmaceuticals Market

11.1      Europe: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Cardinal Health Inc

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Curium

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      GENERAL ELECTRIC

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Lantheus Medical Imaging, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Bayer AG

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Bracco Imaging S.p.A

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      ECZACIBAI MONROL NUCLEAR PRODUCTS CO.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Nordion

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      NTP RADIOISOTOPES

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Advanced Accelerator Applications

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

Table 1.             Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Table 2.             Germany: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             Germany Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4.             Germany Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5.             Germany: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6.             Germany: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 7.             France: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             France Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9.             France Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10.          France: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 11.          France: Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12.          UK: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 13.          UK Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14.          UK Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15.          UK: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          UK: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17.          Italy: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 18.          Italy Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 19.          Italy Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 20.          Italy: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 21.          Italy: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 22.          Spain: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Spain Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 24.          Spain Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 25.          Spain: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 26.          Spain: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 27.          Rest of Europe: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 28.          Rest of Europe Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 29.          Rest of Europe Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 30.          Rest of Europe: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 31.          Rest of Europe: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 32.          Recent Inorganic Growth Strategies

Table 33.          Recent Organic Growth Strategies

Table 34.          Glossary of Terms

Figure 1.           Europe Radiopharmaceuticals Market Segmentation

Figure 2.           Europe Radiopharmaceuticals Market Segmentation, By Country

Figure 3.           Europe Radiopharmaceuticals Market Overview

Figure 4.           Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021

Figure 5.           The UK to Show Significant Growth During Forecast Period

Figure 6.           Europe PEST Analysis

Figure 7.           Europe Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 8.           Europe Radiopharmaceuticals Market– Revenue Forecast and Analysis

Figure 9.           Europe Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 10.        Europe Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Europe SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Europe PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Europe Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Europe Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Europe Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Europe Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Europe Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 18.        Europe Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Europe Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Europe Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Europe Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Europe Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 23.        Europe Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Europe Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Europe Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Europe Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Europe: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 28.        Europe: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 29.        Germany: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        France: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        UK: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        Italy: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        Spain: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.        Rest of Europe: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        Impact of COVID-19 Pandemic in European Country Markets